Compare IVVD & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVVD | IPWR |
|---|---|---|
| Founded | 2020 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.7M | 42.8M |
| IPO Year | 2021 | 2013 |
| Metric | IVVD | IPWR |
|---|---|---|
| Price | $2.40 | $4.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $8.33 | ★ $10.75 |
| AVG Volume (30 Days) | ★ 12.4M | 72.1K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $50,039,000.00 | $43,136.00 |
| Revenue This Year | $103.88 | N/A |
| Revenue Next Year | $171.40 | $3,233.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 332.71 | N/A |
| 52 Week Low | $0.35 | $3.06 |
| 52 Week High | $3.07 | $8.62 |
| Indicator | IVVD | IPWR |
|---|---|---|
| Relative Strength Index (RSI) | 55.98 | 52.58 |
| Support Level | $2.15 | $4.05 |
| Resistance Level | $2.59 | $4.48 |
| Average True Range (ATR) | 0.18 | 0.37 |
| MACD | -0.01 | 0.13 |
| Stochastic Oscillator | 59.80 | 85.42 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.